Novartis to disband cell & gene therapy unit, 120 jobs to go : reuters

referring to reuters

Novartis to disband cell & gene therapy unit, 120 jobs to go

Novartis to disband cell & gene therapy unit, 120 jobs to go

The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland October 27, 2015.REUTERS/Arnd Wiegmann/File PhotoZURICH Novartis is folding activities of its Cell and Gene Therapy unit into other business and research locations, eliminating 120 positions, the Swiss drugmaker said on Wednesday.The move intensifies a corporate makeover begun this year as it focuses on high-growth areas including cancer immunotherapy.


besides endpts

Novartis disbands its pioneering cell and gene therapy unit – ENDPOINTS

Novartis disbands its pioneering cell and gene therapy unit – ENDPOINTS

Novartis is dissolving its high-profile cell and gene therapy unit operating under the guiding hand of Usman "Oz" Azam, Endpoints has learned.Azam has issued a note to the 400 staffers in the group, which was obtained by Endpoints, that says:"The risk of embarking on a new adventure in uncharted territory is that things don't always work out as envisioned.Today, I have the unfortunate task of announcing that we are dissolving the Cell and Gene Therapies Unit."Novartis confirmed that the 400-member group is being disbanded, with most being "redeployed" to new positions while 120 could be left without a job.


not to mention fiercebiotech

UPDATED: As Novartis looks to play catch-up in I/O, it ends cell and gene therapy unit

UPDATED: As Novartis looks to play catch-up in I/O, it ends cell and gene therapy unit

Novartis plans to cut its internal unit dedicated to cell and gene therapy.It will redeploy most of those 400 employees but roughly 120 will be cut, according to reports from Forbes and Endpoints that the company confirmed.The unit was only two years old, a testament to how rapidly immunotherapies are developing--and how hard biopharmas need to work to keep up.